Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity

Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://www3.interscience.wiley.com/cgi-bin/abstract/104536727/START

Online ISSN: 1096-9071    Print ISSN: 0146-6615
Journal of Medical Virology
Volume 70, Issue 4, 2003. Pages: 513-519

Published Online: 2 Jun 2003
 

Copyright © 2003 Wiley-Liss, Inc.

Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity
Peter Vanlandschoot 1 *, Freya Van Houtte 1, Frans Hoek 2, Rienk Nieuwland 2, Geert Leroux-Roels 1
1Center for Vaccinology, Department of Clinical Biology, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium
2Department of Clinical Chemistry, Academic Medical Center, Amsterdam, The Netherlands
 
email: Peter Vanlandschoot (peter.vanlandschoot@rug.ac.be)

*Correspondence to Peter Vanlandschoot, Center for Vaccinology, Department of Clinical Biology, Microbiology and Immunology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.

 

Keywords
rHBsAg • CD14 • lipopolysaccharide binding protein • phospholipid • lipopolysaccharide

 

Abstract
Expression of the hepatitis B virus S protein results in the formation of a lipoprotein particle, the hepatitis B surface antigen (HBsAg). Such particles, produced in Saccharomyces cerevisiae, bind to the cell surface of monocytes through interaction with the lipopolysaccharide binding protein and the lipopolysaccharide receptor, CD14. This attachment is suggested to depend on the presence of charged phospholipids in the particles. In addition, such particles interfere with the lipopolysaccharide and interleukin-2-induced activation of monocytes. In the present study, it is reported that of three Saccharomyces cerevisiae-derived HBsAg preparations, two have a reduced capacity to bind to monocytes. A correlation with a reduced potential to inhibit the lipopolysaccharide-induced activation of monocytes and an increased potential to stimulate HBsAg-specific T-cell proliferation is observed. Surprisingly, differences in phospholipid content that might explain these observations, were not detected. J. Med. Virol. 70:513-519, 2003. © 2003 Wiley-Liss, Inc.

Accepted: 20 February 2003

Copyright © 1999-2003 by John Wiley & Sons, Inc. All rights reserved.
 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.